RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectives

Overview of attention for article published in Pharmacology & Therapeutics, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 42 X users

patent: 1 patent

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

RET INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

Application US-20220135557-A1

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.